NCT06762600View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

January 16, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Overweight or Obesity
Interventions
DRUG

HRS-4729 injection

HRS-4729 injection

DRUG

HRS-4729 injection placebo

HRS-4729 injection placebo

DRUG

HRS9531 injection

HRS9531 injection

DRUG

HRS9531 injection placebo

HRS9531 injection placebo

DRUG

Acetaminophen

Acetaminophen

Trial Locations (1)

250013

RECRUITING

Jinan Central Hospital, Jinan

All Listed Sponsors
lead

Fujian Shengdi Pharmaceutical Co., Ltd.

INDUSTRY